Product image of Metformina (Metformin Hydrochloride) supplied by GNH India

Metformina

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformina (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformina, is a Biguanide presented as an oral tablet for oral use. It is used to lower blood glucose in adults with type 2 diabetes mellitus, improving insulin sensitivity and reducing hepatic glucose output to help achieve glycemic control.

GNH India supplies Metformina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Auxilto Healthcare Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metformina (metformin hydrochloride) is indicated for conditions within the type 2 diabetes therapeutic pathway.
  • Type 2 diabetes mellitus: improves glycemic control by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity.

How It Works

  • Metformin hydrochloride acts primarily by inhibiting mitochondrial respiratory-chain complex I, which reduces hepatic gluconeogenesis. The resulting decrease in hepatic glucose output, together with increased peripheral glucose uptake and improved insulin receptor signaling, leads to lower plasma glucose concentrations without stimulating insulin secretion.

Side Effects

Metformina may be associated with a range of adverse reactions, which are categorized by frequency.

Common Side Effects

  • Nausea: mild to moderate stomach upset, often transient.
  • Diarrhea: loose stools that may occur early in therapy.
  • Abdominal discomfort: cramping or bloating.
  • Metallic taste: transient alteration in taste perception.
  • Decreased appetite: reduced desire to eat.
  • Weight loss: modest reduction in body weight.

Serious or Rare Side Effects

  • Lactic acidosis: a rare but life‑threatening accumulation of lactate.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Vitamin B12 deficiency: may develop with long‑term use.
  • Hepatic failure: rare impairment of liver function.
  • Pancreatitis: inflammation of the pancreas, presenting with abdominal pain.

Precautions & Warnings

  • When prescribing Metformina, clinicians should consider several safety measures.
  • Renal function assessment: evaluate creatinine clearance before initiating therapy.
  • Hepatic function monitoring: avoid use in patients with significant liver disease.
  • Risk of lactic acidosis: contraindicated in severe renal impairment, acute heart failure, or conditions predisposing to hypoxia.
  • Elderly patients: start at lower doses and monitor for accumulation.
  • Alcohol consumption: advise patients to limit intake to reduce lactic acidosis risk.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Metformina can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
  • Cimetidine: can raise metformin plasma concentrations.
  • Alcohol: potentiates the risk of lactic acidosis.
  • Renal‑impairing drugs (e.g., NSAIDs): may reduce metformin clearance.
  • Carbamazepine: may decrease metformin effectiveness.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycemia symptoms.
  • Thiazide diuretics: can enhance hypoglycemic effect.
  • ACE inhibitors or ARBs: may affect renal function, requiring dose adjustment.
  • Corticosteroids: may increase blood glucose, necessitating closer monitoring.
  • Oral contraceptives: may slightly raise metformin levels.

Frequently Asked Questions

Metformina contains metformin hydrochloride, an oral antidiabetic drug used primarily to improve blood‑sugar control in adults with type 2 diabetes mellitus. It works by lowering hepatic glucose production and increasing the body's sensitivity to insulin, helping patients achieve target glycemic levels.

Metformin hydrochloride inhibits mitochondrial complex I, which reduces the liver's production of glucose. It also enhances peripheral tissue uptake of glucose and improves insulin receptor signaling, resulting in lower plasma glucose without directly stimulating insulin secretion.

The exact dose of Metformina is determined by the prescribing clinician based on the individual’s renal function, glycemic targets, and overall health status. Dosage adjustments are made during treatment to achieve optimal blood‑glucose control while minimizing side effects.

The safety of metformin during pregnancy or lactation is not fully established, and the product’s pregnancy category is listed as unknown. Clinicians should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing patients.

To request Metformina, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformina belongs to the biguanide class, differing from sulfonylureas, DPP‑4 inhibitors, or SGLT2 inhibitors. Unlike insulin‑secretagogues, it does not cause direct insulin release, reducing hypoglycemia risk. Its glucose‑lowering effect is primarily through hepatic and peripheral mechanisms, making it a first‑line option for many patients.

Metformina should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the tablets in a dry, cool environment helps maintain potency throughout the product’s shelf life.

Metformina is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets are swallowed whole with a full glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or significant hypoxia. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformina is contraindicated in individuals with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those receiving iodinated contrast studies without adequate renal monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT